Skip to content
Medx

Tag: Arcoxia

Explore our medication guides and pharmacology articles within this category.

Why is etoricoxib banned in the US? A deep dive into the FDA's decision

•
4 min read
In 2007, an FDA advisory committee voted 20 to 1 against approving etoricoxib (Arcoxia), determining that its cardiovascular risks did not justify its therapeutic benefits. This rejection effectively banned the COX-2 inhibitor from the US market, a significant event in the wake of similar safety controversies.

Is etoricoxib a strong painkiller? An In-depth Pharmacological Analysis

•
3 min read
In clinical trials involving acute postoperative pain, a single dose of etoricoxib provided significant pain relief for an extended period, confirming that **is etoricoxib a strong painkiller**. This powerful selective non-steroidal anti-inflammatory drug (NSAID) offers substantial analgesic effects for various pain conditions.